(Q41649129)

6 October 2017

title

Systemic gene delivery expands the repertoire of effective antiangiogenic agents (English)

1 reference

6 October 2017

main subject

angiogenesis inhibitor

1 reference

Liu Y

1

1 reference

6 October 2017

Thor A

2

1 reference

6 October 2017

Shtivelman E

3

1 reference

6 October 2017

Cao Y

4

1 reference

6 October 2017

Tu G

5

1 reference

6 October 2017

Heath TD

6

1 reference

6 October 2017

Debs RJ

7

1 reference

6 October 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

Journal of Biological Chemistry

6 October 2017

published in

1 reference

6 October 2017

volume

274

1 reference

6 October 2017

issue

19

1 reference

6 October 2017

page(s)

13338-13344

1 reference

The tumor suppressor genes

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

The multistep nature of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

Application of antisense technology to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

Therapeutic applications of ribozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

Improved DNA: liposome complexes for increased systemic delivery and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

Cationic liposome-mediated intravenous gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

An improved plasmid DNA expression vector for direct injection into skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

Oncogenes as inducers of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

Genetic mechanisms of tumor suppression by the human p53 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

p53 function and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.19.13338

21 January 2018

Identifiers

DOI

10.1074/JBC.274.19.13338

1 reference

6 October 2017

1 reference